NasdaqGS - Delayed Quote USD
Aclaris Therapeutics, Inc. (ACRS)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 5:13 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.9M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Nov 1, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Oct 1, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Aug 30, 2024 |
| BALTHASER KEVIN J Chief Financial Officer | -- | Direct | -- | Aug 30, 2024 |
| WALKER NEAL Chief Executive Officer | Conversion of Exercise of derivative security at price 0.72 per share. | Direct | 31,355 | Aug 9, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.24 - 1.29 per share. | Indirect | 472,757 | Aug 5, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Aug 1, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.30 - 1.33 per share. | Indirect | 359,010 | Jul 31, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.30 - 1.33 per share. | Indirect | 201,808 | Jul 22, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.14 - 1.16 per share. | Indirect | 405,894 | Jul 5, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.12 - 1.15 per share. | Indirect | 1,742,075 | Jul 1, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Jul 1, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.13 - 1.17 per share. | Indirect | 628,206 | Jun 18, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.08 - 1.15 per share. | Indirect | 1,781,897 | Jun 13, 2024 |
| MILANO VINCENT J Director | -- | Direct | -- | May 31, 2024 |
| SCHIFF ANDREW N Director | -- | Direct | -- | May 31, 2024 |
| GOWEN MAXINE Director | -- | Direct | -- | May 31, 2024 |
| POWELL ANDREW KENNETH WILLIAM Director | -- | Direct | -- | May 31, 2024 |
| REASONS BRYAN M Director | -- | Direct | -- | May 31, 2024 |
| MEHRA ANAND Director | -- | Direct | -- | May 31, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | May 31, 2024 |
| MOLINEAUX CHRISTOPHER P Director | -- | Direct | -- | May 31, 2024 |
| HUMPHRIES WILLIAM DOUGLAS Director | -- | Direct | -- | May 31, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | May 1, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Apr 1, 2024 |
| POWELL ANDREW KENNETH WILLIAM Director | Purchase at price 1.23 - 1.25 per share. | Direct | 17,955 | Mar 4, 2024 |
| WALKER NEAL Chief Executive Officer | -- | Direct | -- | Mar 1, 2024 |
| MONAHAN JOSEPH B Officer | -- | Direct | -- | Mar 1, 2024 |
| BALTHASER KEVIN J Chief Financial Officer | -- | Direct | -- | Mar 1, 2024 |
| LOEROP JAMES Officer | -- | Direct | -- | Feb 1, 2024 |
| MONAHAN JOSEPH B Officer | -- | Direct | -- | Feb 1, 2024 |
| MANION DOUGLAS J Chief Executive Officer | -- | Direct | -- | Dec 29, 2023 |
| BALTHASER KEVIN J Chief Financial Officer | -- | Direct | -- | Dec 29, 2023 |
| MONAHAN JOSEPH B Officer | Sale at price 5.08 per share. | Direct | 30,460 | Oct 23, 2023 |
| BALTHASER KEVIN J Chief Financial Officer | Purchase at price 7.90 per share. | Direct | 74,971 | Sep 6, 2023 |
| BALTHASER KEVIN J Chief Financial Officer | -- | Direct | -- | Sep 1, 2023 |
| LOEROP JAMES Officer | Purchase at price 6.80 per share. | Direct | 99,959 | Aug 28, 2023 |
| MONAHAN JOSEPH B Officer | Sale at price 7.32 per share. | Direct | 43,895 | Aug 21, 2023 |
| MANION DOUGLAS J Chief Executive Officer | -- | Direct | -- | Aug 1, 2023 |
| CAWKWELL GAIL Officer | -- | Direct | -- | Jun 30, 2023 |
| MONAHAN JOSEPH B Officer | Sale at price 10.28 per share. | Direct | 61,663 | Jun 20, 2023 |
| MOLINEAUX CHRISTOPHER P Director | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 23,265 | Jun 20, 2023 |
| MOLINEAUX CHRISTOPHER P Director | Conversion of Exercise of derivative security at price 0.72 - 1.52 per share. | Direct | 338 | Jun 15, 2023 |
| MILANO VINCENT J Director | -- | Direct | -- | Jun 2, 2023 |
| SCHIFF ANDREW N Director | -- | Direct | -- | Jun 2, 2023 |
| GOWEN MAXINE Director | -- | Direct | -- | Jun 2, 2023 |
| POWELL ANDREW KENNETH WILLIAM Director | -- | Direct | -- | Jun 2, 2023 |
| REASONS BRYAN M Director | -- | Direct | -- | Jun 2, 2023 |
| MEHRA ANAND Director | -- | Direct | -- | Jun 2, 2023 |
| MOLINEAUX CHRISTOPHER P Director | -- | Direct | -- | Jun 2, 2023 |
Related Tickers
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
STIM Neuronetics, Inc.
0.7100
-10.13%
NOTV Inotiv, Inc.
2.6800
-1.83%
PSNL Personalis, Inc.
3.8900
-9.53%
NDRA ENDRA Life Sciences Inc.
4.5400
-14.34%
PRE Prenetics Global Limited
4.5000
-5.26%
ENZ Enzo Biochem, Inc.
1.0400
0.00%
GENE Genetic Technologies Limited
0.7650
0.00%
VCYT Veracyte, Inc.
35.94
-2.97%
PRPO Precipio, Inc.
6.19
-0.77%